Biofrontera AG expected to post a loss of 9  cents a share - Earnings Preview

Biofrontera AG

06/05/2022 19:35

* Biofrontera AG  B8FGn.DE   is expected to show a rise in
quarterly revenue when it reports  results on May 9
(estimated). 
    * The Leverkusen Nordrhein-westfalen-based  company is
expected to
report  a 77.0% increase in revenue to €9.7 million from €5.48
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Biofrontera AG is
for a
loss of 9 cents per share. For the same quarter last year, the
company reported a loss of 9 cents per share.
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for
the pharmaceuticals
peer group is also "Buy".​
    * Wall Street's median 12-month price target for Biofrontera
AG is
€5.27​, above​ its last closing price of €1.06. ​​​

This summary was machine generated May 6 at 18:34 GMT.  All
figures in euros  unless otherwise stated